SCHEMBL10110196

SCHEMBL10110196

COOCc1cccc(C(=O)OC)c1-n1cccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
LMNA P02545 2/20 0.41
KMT2A Q03164 2/20 0.40
MAPK8 P45983 1/20 0.40
MAPK9 P45984 1/20 0.40
MAPK10 P53779 1/20 0.40
HTT P42858 1/20 0.39
TSHR P16473 2/20 0.38
CFTR P13569 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MAPT P10636 1/20 0.37
PTPRC P08575 1/20 0.37
GAA P10253 1/20 0.37
KDM4E B2RXH2 2/20 0.36
POLB P06746 1/20 0.36
ATM Q13315 1/20 0.36
MYC P01106 1/20 0.36
HIF1A Q16665 1/20 0.36
AHR P35869 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2158508 0.82 ALDH1A1 (0.50) ALDH1A1LMNAKMT2ATSHRCFTR
SCHEMBL10103507 0.76 HTR7 (0.47) ALDH1A1LMNAKMT2AHTTTSHR
SCHEMBL6747916 0.75 NR4A2 (0.47) ALDH1A1LMNAKMT2ATSHRCFTR
SCHEMBL16719847 0.75 KMT2A (0.47) ALDH1A1LMNAKMT2AHTTTSHR
SCHEMBL13515011 0.74 ALDH1A1 (0.46) ALDH1A1LMNAKMT2AMAPK8MAPK9
SCHEMBL16719289 0.71 ALDH1A1 (0.42) ALDH1A1LMNAKMT2ATSHRCFTR
SCHEMBL6568367 0.70 TSHR (0.44) ALDH1A1LMNAKMT2ATSHRCFTR
SCHEMBL6571494 0.70 ALDH1A1 (0.48) ALDH1A1LMNAKMT2ACFTRHSD17B10
SCHEMBL25517666 0.69 ALDH1A1 (0.40) ALDH1A1LMNAKMT2ATSHRCFTR
SCHEMBL26154445 0.69 KMT2A (0.42) ALDH1A1LMNAKMT2ATSHRCFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178687-B2 Derivatives of pyrroloindole which are inhibitors of Hsp90, compositions containing same, and use thereof SANOFI-AVENTIS (FR) 2012-05-15 US disclosed
US-20110184015-A1 NOVEL DERIVATIVES OF PYRROLOINDOLE WHICH ARE INHIBITORS OF HSP90, COMPOSITIONS CONTAINING SAME, AND USE THEREOF SANOFI-AVENTIS (FR) 2011-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110184015-A1 NOVEL DERIVATIVES OF PYRROLOINDOLE WHICH ARE INHIBITORS OF HSP90, COMPOSITIONS CONTAINING SAME, AND USE THEREOF HSP90AB1, HSP90AB2P, HSP90AA1 ALDH1A1 2129/4885LMNA 3855/4885KMT2A 4671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.